1
Publications
26
Citations
1
H-Index
2022
Active since
Affiliations
CytomX Therapeutics (United States)(Current)
Amy DuPage is an author at CytomX Therapeutics (United States).
Publications per year
2022–2022
1
1
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate
Shweta Singh, Laura Serwer, Amy DuPage et al. · Molecular Cancer Therapeutics · 2022 · 26 citations · Full text
Rows per page
1–1 of 1